Andrea Cossarizza

Andrea Cossarizza (born December 11th, 1958) took the degree in Medicine and Surgery at the University of Padua, then did his PhD in Oncology at the University of Bologna and University of Modena, and the Specialization in Clinical Pathology and Immunohematology at the University of Modena and Reggio Emilia. Since he was a medical student, he visited the Basel Institute of Immunology and then NYU. After some periods in different Institutes (Charing Cross Sunley Res. Ctr., London; Univ. Cochin, Paris; UCLA), in 1998 he became Associate Professor of General Pathology and Immunology at the University of Modena and Reggio Emilia, and in 2010 was appointed Full Professor. SCIENTIFIC ACTIVITY As of August 2nd, 2019, Dr. Cossarizza has published 335 full papers on peer-reviewed international journals (PubMed; other 4 are in press) with a total impact factor: 1,413 and H-index: 79 (by Google Scholar), among which Science, Nature Communications, Nature Protocols, The Lancet, The Lancet Infectious Diseases, Proc. Natl. Acad. Sci. USA, Immunol. Today, Gastroenterology, Circulation, J. Am. Coll. Cardiol., Blood, Brain, J. Immunol., J. Biol. Chem., Endocrine Reviews, AIDS, Eur. J. Immunol., J. Infect. Dis., Clin. Infect. Dis., Am. J. Pathol. His current main scientific interests can be summarized as follows: 1. characterization of the immune reponse and search for predictiove markers in patients treated with biological drugs (checkpoint inhibitors, anti-cytokines) 2. analysis of the alterations of the immune system during different human diseases and infections, and in particular during HIV infection and autoimmune disorders; 3. analysis of the changes that occur in the immune system during aging and longevity; 4. analysis of the role of mitochondria in the process of apoptosis and importance of mitochondrial DNA in a variety of pathologies. In the past, two other topics were deeply studied, i.e.: 1. biological effects of non-ionizing radiations (pulsed magnetic fields); 2. ontogenesis and phylogenesis of the immune system.